Gene Expression Signature With Independent Prognostic Significance in Epithelial Ovarian Cancer
Top Cited Papers
- 1 December 2004
- journal article
- gynecologic cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (23), 4700-4710
- https://doi.org/10.1200/jco.2004.04.070
Abstract
Purpose Currently available clinical and molecular prognostic factors provide an imperfect assessment of prognosis for patients with epithelial ovarian cancer (EOC). In this study, we investigated ...Keywords
This publication has 42 references indexed in Scilit:
- Overexpression of Her-2/neu in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-κB: Implications for malignant ascites formation and tumor lymphangiogenesisJournal of Biomedical Science, 2004
- Genes@Work: an efficient algorithm for pattern discovery and multivariate feature selection in gene expression dataBioinformatics, 2004
- Gene expression profile after cardiopulmonary bypass and cardioplegic arrestThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Expression profiling of epithelial plasticity in tumor progressionOncogene, 2003
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemiaNature Genetics, 2001
- Clinical Relevance of the Plasminogen Activator Inhibitor Type1 – a Multifaceted Proteolytic FactorOncology Research and Treatment, 2001
- Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patientsInternational Journal of Cancer, 1998
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996